CorMedix Inc
NASDAQ:CRMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CorMedix Inc
NASDAQ:CRMD
|
US |
|
S
|
Swatch Group AG
XMUN:UHRN
|
CH |
|
C
|
Corning Inc
DUS:GLW
|
US |
|
O
|
Origin Property PCL
SET:ORI
|
TH |
|
Bilfinger SE
F:GBF
|
DE |
|
M
|
Masco Corp
XBER:MSQ
|
US |
|
H
|
Henderson Land Development Co Ltd
F:HLD
|
HK |
|
Acarix AB
F:7AC
|
SE |
|
C
|
Cooper Energy Ltd
OTC:COPJF
|
AU |
|
D
|
Diageo PLC
OTC:DGEAF
|
UK |
Wall St Price Targets
CRMD Price Targets Summary
CorMedix Inc
According to Wall Street analysts, the average 1-year price target for CRMD is 15.64 USD with a low forecast of 13.13 USD and a high forecast of 19.95 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CRMD's stock price target?
Price Target
15.64
USD
According to Wall Street analysts, the average 1-year price target for CRMD is 15.64 USD with a low forecast of 13.13 USD and a high forecast of 19.95 USD.
What is the Revenue forecast for CorMedix Inc?
Projected CAGR
4%
The compound annual growth rate for Revenue over the next 3 years is 4%.
What is the Gross Profit forecast for CorMedix Inc?
Projected CAGR
-1%
The compound annual growth rate for Gross Profit over the next 3 years is -1%.
What is the Operating Income forecast for CorMedix Inc?
Projected CAGR
-25%
The compound annual growth rate for Operating Income over the next 3 years is -25%.
What is the Pre-Tax Income forecast for CorMedix Inc?
Projected CAGR
-28%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -28%.
What is the Net Income forecast for CorMedix Inc?
Projected CAGR
-36%
The compound annual growth rate for Net Income over the next 3 years is -36%.
